Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HFD3
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.706 |
DEG_COP1_1 | 5 | 12 | PF00400 | 0.509 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.589 |
DOC_CKS1_1 | 111 | 116 | PF01111 | 0.488 |
DOC_CYCLIN_yClb1_LxF_4 | 90 | 96 | PF00134 | 0.625 |
DOC_CYCLIN_yCln2_LP_2 | 196 | 202 | PF00134 | 0.635 |
DOC_PP2B_LxvP_1 | 175 | 178 | PF13499 | 0.649 |
DOC_PP2B_LxvP_1 | 190 | 193 | PF13499 | 0.461 |
DOC_PP2B_LxvP_1 | 200 | 203 | PF13499 | 0.507 |
DOC_USP7_MATH_1 | 140 | 144 | PF00917 | 0.662 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.518 |
DOC_USP7_UBL2_3 | 201 | 205 | PF12436 | 0.629 |
DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.663 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.604 |
DOC_WW_Pin1_4 | 126 | 131 | PF00397 | 0.418 |
DOC_WW_Pin1_4 | 163 | 168 | PF00397 | 0.573 |
LIG_Actin_WH2_2 | 111 | 127 | PF00022 | 0.487 |
LIG_BRCT_BRCA1_1 | 142 | 146 | PF00533 | 0.642 |
LIG_CtBP_PxDLS_1 | 156 | 160 | PF00389 | 0.700 |
LIG_EVH1_1 | 175 | 179 | PF00568 | 0.677 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.747 |
LIG_FHA_1 | 206 | 212 | PF00498 | 0.613 |
LIG_FHA_1 | 56 | 62 | PF00498 | 0.470 |
LIG_LIR_Gen_1 | 185 | 195 | PF02991 | 0.675 |
LIG_LIR_Nem_3 | 185 | 190 | PF02991 | 0.549 |
LIG_SH2_NCK_1 | 181 | 185 | PF00017 | 0.591 |
LIG_SH2_PTP2 | 25 | 28 | PF00017 | 0.454 |
LIG_SH2_STAT5 | 187 | 190 | PF00017 | 0.675 |
LIG_SH2_STAT5 | 25 | 28 | PF00017 | 0.616 |
LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.284 |
LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.280 |
LIG_SH3_1 | 180 | 186 | PF00018 | 0.536 |
LIG_SH3_2 | 120 | 125 | PF14604 | 0.659 |
LIG_SH3_3 | 105 | 111 | PF00018 | 0.656 |
LIG_SH3_3 | 117 | 123 | PF00018 | 0.658 |
LIG_SH3_3 | 142 | 148 | PF00018 | 0.641 |
LIG_SH3_3 | 173 | 179 | PF00018 | 0.693 |
LIG_SH3_3 | 180 | 186 | PF00018 | 0.515 |
LIG_SH3_3 | 23 | 29 | PF00018 | 0.658 |
LIG_SH3_3 | 48 | 54 | PF00018 | 0.598 |
LIG_TRFH_1 | 95 | 99 | PF08558 | 0.537 |
LIG_WW_1 | 178 | 181 | PF00397 | 0.547 |
MOD_CK1_1 | 110 | 116 | PF00069 | 0.601 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.703 |
MOD_CK1_1 | 160 | 166 | PF00069 | 0.651 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.552 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.651 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.626 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.512 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.535 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.607 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.588 |
MOD_GSK3_1 | 201 | 208 | PF00069 | 0.678 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.516 |
MOD_N-GLC_1 | 12 | 17 | PF02516 | 0.658 |
MOD_N-GLC_1 | 138 | 143 | PF02516 | 0.626 |
MOD_N-GLC_1 | 2 | 7 | PF02516 | 0.567 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.609 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.535 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.647 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.495 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.509 |
MOD_PIKK_1 | 118 | 124 | PF00454 | 0.718 |
MOD_PIKK_1 | 134 | 140 | PF00454 | 0.406 |
MOD_PIKK_1 | 55 | 61 | PF00454 | 0.299 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.628 |
MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.664 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.601 |
MOD_ProDKin_1 | 126 | 132 | PF00069 | 0.417 |
MOD_ProDKin_1 | 163 | 169 | PF00069 | 0.573 |
TRG_ENDOCYTIC_2 | 187 | 190 | PF00928 | 0.675 |
TRG_ENDOCYTIC_2 | 25 | 28 | PF00928 | 0.486 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I344 | Leptomonas seymouri | 71% | 100% |
A0A0S4ISK2 | Bodo saltans | 43% | 100% |
A0A1X0NLP8 | Trypanosomatidae | 46% | 90% |
A0A3S7X0C4 | Leishmania donovani | 90% | 100% |
A0A422NXG6 | Trypanosoma rangeli | 54% | 81% |
A4I361 | Leishmania infantum | 91% | 100% |
C9ZKV4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 89% |
E9ACZ2 | Leishmania major | 89% | 100% |
E9AYR7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
V5DCD8 | Trypanosoma cruzi | 51% | 81% |